Cellectis S.A Shares Outstanding History (CLLS)
Cellectis S.A reported 100.3M shares outstanding at the end of fiscal 2025.
View full Cellectis S.A company overviewCellectis S.A annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 100.3M | 245,568 | +0.25% |
| 2024 | 2024-12-31 | 100.1M | 28.3M | +39.50% |
| 2023 | 2023-12-31 | 71.8M | 26.1M | +57.09% |
| 2022 | 2022-12-31 | 45.7M | 191,658 | +0.42% |
| 2021 | 2021-12-31 | 45.5M | 2.7M | +6.32% |
| 2020 | 2020-12-31 | 42.8M | 314,517 | +0.74% |
| 2019 | 2019-12-31 | 42.5M | 35,600 | +0.08% |
| 2018 | 2018-12-31 | 42.4M | 6.5M | +17.99% |
| 2017 | 2017-12-31 | 36.0M | 625,002 | +1.77% |
| 2016 | 2017-01-01 | 35.3M | 156,446 | +0.44% |
| 2015 | 2016-01-01 | 35.2M | 5.7M | +19.47% |
| 2014 | 2014-12-31 | 29.4M | — | — |
Cellectis S.A quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 100.3M | 28.6M | +39.84% |
| Q2 2025 | 2025-06-30 | 100.3M | 44.7M | +80.49% |
| Q4 2024 | 2024-12-31 | 100.1M | 54.4M | +119.14% |
| Q2 2024 | 2024-06-30 | 100.1M | 54.6M | +119.93% |
| Q4 2023 | 2023-12-31 | 71.8M | 26.3M | +57.75% |
| Q2 2023 | 2023-06-30 | 55.6M | 10.1M | +22.27% |
| Q4 2022 | 2022-12-31 | 45.7M | 2.9M | +6.77% |
| Q2 2022 | 2022-06-30 | 45.5M | 3.0M | +7.12% |
| Q4 2021 | 2021-12-31 | 45.5M | 3.0M | +7.11% |
| Q2 2021 | 2021-06-30 | 45.5M | 3.0M | +7.14% |
| Q4 2020 | 2020-12-31 | 42.8M | 6.8M | +18.97% |
| Q2 2020 | 2020-06-30 | 42.5M | 7.2M | +20.24% |
| Q4 2019 | 2019-12-31 | 42.5M | 7.3M | +20.71% |
| Q4 2018 | 2018-12-31 | 42.4M | 13.0M | +44.09% |
| Q4 2017 | 2017-12-31 | 36.0M | — | — |
| Q4 2016 | 2017-01-01 | 35.3M | — | — |
| Q4 2015 | 2016-01-01 | 35.2M | — | — |
| Q4 2014 | 2014-12-31 | 29.4M | — | — |
Cellectis S.A shares outstanding trends
Over the last five reported fiscal years, Cellectis S.A's shares outstanding moved from 42.8M to 100.3M, a change of 57.6M. The latest reported quarter, Q4 2025, shows 100.3M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cellectis S.A filings at SEC.gov ↗